Literature DB >> 7007520

An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis.

Y Naot, J S Remington.   

Abstract

In an enzyme-linked immunosorbent assay (ELISA) for detection of IgM antibodies to Toxoplasma gondii, sera from individuals with negative results in the Sabin-Feldman dye test (DT) and sera from individuals with chronic toxoplasma infection all yielded negative results, even when tested undiluted. In contrast, of sera obtained from individuals with recently acquired toxoplasmosis, all sera that gave positive results in both the DT and the IgM-immunofluorescent antibody (IgM-IFA) test and 92.8% of sera that gave negative results in the IgM-IFA test yielded strongly positive results in the IgM-ELISA. Thus, the IgM-ELISA is more sensitive than the IgM-IFA test in the diagnosis of recently acquired infection with T. gondii. Moreover, sera that gave negative results in the DT but that contained either antinuclear antibodies or rheumatoid factor and thus caused false-positive results in the IgM-IFA test all yielded negative results in the IgM-ELISA, probably because serum IgM and IgG fractions were separated during the initial step.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7007520     DOI: 10.1093/infdis/142.5.757

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  79 in total

1.  VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.

Authors:  Jose G Montoya; Oliver Liesenfeld; Sandra Kinney; Cynthia Press; Jack S Remington
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  Latex agglutination assay of human immunoglobulin M antitoxoplasma antibodies which uses enzymatically treated antigen-coated particles.

Authors:  C L Cambiaso; L M Galanti; P Leautaud; P L Masson
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Detection of Entamoeba histolytica immunoglobulins G and M to plasma membrane antigen by enzyme-linked immunosorbent assay.

Authors:  M A Sathar; B L Bredenkamp; V Gathiram; A E Simjee; T F Jackson
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

4.  Improvement of immunoglobulin M capture immunoassay specificity: toxoplasma antibody detection method as a model.

Authors:  T Tuuminen; H Seppänen; E M Pitkänen; P Palomäki; K Käpyaho
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

5.  Evaluation of an enzyme immunoassay for IgM antibodies to Treponema pallidum in syphilis in man.

Authors:  F Müller; M Moskophidis
Journal:  Br J Vener Dis       Date:  1984-10

6.  Toxoplasma antigens recognized by naturally occurring human antibodies.

Authors:  I Potasman; F G Araujo; J S Remington
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

7.  Rapid double-sandwich enzyme-linked immunosorbent assay for detection of human immunoglobulin M anti-Toxoplasma gondii antibodies.

Authors:  J P Tomasi; A F Schlit; S Stadtsbaeder
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

8.  Enzyme-linked immunosorbent assay for detection of soluble Toxoplasma gondii antigen in acute-phase toxoplasmosis.

Authors:  E G Lindenschmidt
Journal:  Eur J Clin Microbiol       Date:  1985-10       Impact factor: 3.267

9.  Role of lymphocyte blastogenesis to Toxoplasma gondii antigens in containment of chronic, latent T. gondii infection in humans.

Authors:  R McLeod; R G Estes
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

10.  Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women.

Authors:  David C Kasper; Andrea R Prusa; Michael Hayde; Nicole Gerstl; Arnold Pollak; Kurt R Herkner; Rosmarie Reiter-Reisacher
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.